Higher expression of miR‐125a may predict better survival in NSCLC patients.14, 34, 35, 36, 37Wang et al reported that miR‐125a, as a metastatic suppressor in lung cancer cells, activated by epidermal growth factor receptor (EGFR) signaling, inhibits tumorigenesis and tube formation.38 In our study, rs8111742 located 1033bp upstream of miR‐125a was associated with better survival in NSCLC patients. Here, EGFR is linked to non-small cell lung carcinoma.